<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01930487</url>
  </required_header>
  <id_info>
    <org_study_id>007</org_study_id>
    <nct_id>NCT01930487</nct_id>
  </id_info>
  <brief_title>The Effects of an Antioxidant Formulation on Ocular Blood Flow</brief_title>
  <official_title>The Effects of an Antioxidant Formulation on Intraocular Pressure, Ocular Perfusion Pressure, Retrobulbar, Retinal Capillary and Choroidal Blood Flow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ScienceBased Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ScienceBased Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to evaluate the effects of an antioxidant formula versus placebo on ocular
      blood flow in a randomized double-blind, crossover design.

      Based upon preliminary data, it is hypothesized that a dietary supplement containing a
      variety of ingredients with antioxidant properties will, compared to placebo, increase ocular
      perfusion pressure, retrobulbar, retinal capillary and choroidal blood flow, and maintain
      these effects over the course of the treatment period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Ocular Perfusion Pressure</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ocular perfusion pressure (2/3 Mean arterial pressure - intraocular pressure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ocular Perfusion Pressure - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ocular Perfusion Pressure - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</measure>
    <time_frame>baseline and 30 days</time_frame>
    <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>supplement w/ antioxidants then placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dietary supplement with antioxidants, followed by placebo supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo then supplement w/ antioxidants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>placebo supplement, followed by dietary supplement with antioxidants</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>dietary supplement with antioxidants</intervention_name>
    <description>Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
    <arm_group_label>supplement w/ antioxidants then placebo</arm_group_label>
    <arm_group_label>placebo then supplement w/ antioxidants</arm_group_label>
    <other_name>Optic Nerve Formula</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo - Softgels manufactured to mimic the appearance of active, dietary supplement with antioxidants</description>
    <arm_group_label>supplement w/ antioxidants then placebo</arm_group_label>
    <arm_group_label>placebo then supplement w/ antioxidants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 30 years or older.

          -  Confirmed diagnosis of open angle glaucoma by glaucoma specialist in the study eye, as
             evidenced from criteria representative of glaucomatous optic nerve damage such as
             specific optic disc or retinal nerve fiber layer structural abnormalities and/or
             visual field abnormalities.

          -  Best corrected visual acuity at 20/60 or better in study eye.

          -  Willingness to avoid caffeine and smoking for 12 hours before and during the study
             visits.

        Exclusion Criteria:

          -  History of acute angle-closure or a narrow, occluding of anterior chamber angle by
             gonioscopy.

          -  History of chronic or recurrent inflammatory eye diseases or signs of intraocular
             trauma and/or unreliable applanation tonometry.

          -  Severe, unstable or uncontrolled cardiovascular, renal or pulmonary disease

          -  History of/or current renal or hepatic impairment.

          -  History of/or current bronchial asthma, severe chronic obstructive pulmonary disease,
             sinus bradycardia, second or third degree atrioventricular block, or cardiogenic
             shock.

          -  Recent surgery or surgery planned near study timeline

          -  History of bleeding disorder

          -  Use of blood thinning medications

          -  Use of specified dietary supplements for three weeks prior to study entry and
             throughout study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alon Harris, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Ophthalmology, Professor of Cellular and Integrative Physiology, Director Clinical Research Glick Eye Institute, Indiana University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glick Eye Institute, Ocular Vascular Research Center, Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2013</study_first_submitted>
  <study_first_submitted_qc>August 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2013</study_first_posted>
  <results_first_submitted>May 31, 2016</results_first_submitted>
  <results_first_submitted_qc>October 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 5, 2016</results_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary open angle glaucoma</keyword>
  <keyword>intraocular pressure</keyword>
  <keyword>ocular perfusion pressure</keyword>
  <keyword>retrobulbar blood flow</keyword>
  <keyword>retinal capillary blood flow</keyword>
  <keyword>choroidal blood flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>47 patients were recruited for the study</recruitment_details>
      <pre_assignment_details>1 subject started but did not complete the baseline examination and was not randomized to either treatment arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Supplement With Antioxidants, Then Placebo</title>
          <description>dietary supplement with antioxidants in the first intervention period, followed by placebo supplement in the second intervention period</description>
        </group>
        <group group_id="P2">
          <title>Placebo, Then Supplement With Antioxidants</title>
          <description>placebo supplement in the second intervention period, followed by dietary supplement with antioxidants in the second intervention period</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (30 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period (3 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (30 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>patients who completed both periods of the crossover study</population>
      <group_list>
        <group group_id="B1">
          <title>Participants Completing Study</title>
          <description>Participants who completed both arms of the crossover study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes (Type 2)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Study Eye</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>right</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>left</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of OAG</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels)</title>
        <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels)</title>
          <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.026" spread="0.008"/>
                    <measurement group_id="O2" value="0.011" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0016</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.037</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.011</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants - placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels)</title>
        <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels)</title>
          <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF)</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.016" spread="0.007"/>
                    <measurement group_id="O2" value="0.009" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0249</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.025</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.011</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants - placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ocular Perfusion Pressure</title>
        <description>change (post-treatment - pre-treatment) in ocular perfusion pressure (2/3 Mean arterial pressure - intraocular pressure)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ocular Perfusion Pressure</title>
          <description>change (post-treatment - pre-treatment) in ocular perfusion pressure (2/3 Mean arterial pressure - intraocular pressure)</description>
          <population>patients completing both study periods</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.9"/>
                    <measurement group_id="O2" value="1.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.9147</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.1</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.3</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants - placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.41"/>
                    <measurement group_id="O2" value="-0.94" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0070</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.67</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.59</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants - placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="0.15"/>
                    <measurement group_id="O2" value="-0.43" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>paired t-test, 2-sidede</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.97</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants - placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" spread="0.14"/>
                    <measurement group_id="O2" value="-0.16" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0476</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.46</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.23</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.16"/>
                    <measurement group_id="O2" value="-0.14" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0352</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.45</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.13"/>
                    <measurement group_id="O2" value="-0.17" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0208</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.21</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.05"/>
                    <measurement group_id="O2" value="-0.11" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.38</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.07</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.05"/>
                    <measurement group_id="O2" value="-0.07" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0024</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.24</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.07</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s)</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.05"/>
                    <measurement group_id="O2" value="-0.06" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0081</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.21</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.07</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio)</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio)</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.007" spread="0.004"/>
                    <measurement group_id="O2" value="-0.005" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8191</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.002</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.008</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio)</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio)</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.018" spread="0.006"/>
                    <measurement group_id="O2" value="0.000" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0482</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.018</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.009</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.013" spread="0.006"/>
                    <measurement group_id="O2" value="0.005" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0230</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.019</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.0230</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery Blood Flow - Vascular Resistance (Ratio)</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI)</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.009" spread="0.006"/>
                    <measurement group_id="O2" value="0.004" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1202</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.013</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.008</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.71" spread="0.56"/>
                    <measurement group_id="O2" value="-0.84" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0063</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.55</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.83</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.24" spread="0.53"/>
                    <measurement group_id="O2" value="-1.03" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3347</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.80</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.80</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.20"/>
                    <measurement group_id="O2" value="-0.44" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0094</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.02</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.35</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.23"/>
                    <measurement group_id="O2" value="-0.41" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0009</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.92</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.24</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.56" spread="0.22"/>
                    <measurement group_id="O2" value="-0.46" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0067</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.02</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.34</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.16"/>
                    <measurement group_id="O2" value="0.13" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6938</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.10</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.25</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.19"/>
                    <measurement group_id="O2" value="-0.32" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0805</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.56</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.30</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery Peak Systolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery peak systolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" spread="0.27"/>
                    <measurement group_id="O2" value="0.03" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2451</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.35</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.29</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.60" spread="0.19"/>
                    <measurement group_id="O2" value="-0.18" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0323</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.78</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.34</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.18"/>
                    <measurement group_id="O2" value="-0.16" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3440</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.25</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.26</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.06"/>
                    <measurement group_id="O2" value="-0.08" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0119</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.37</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.13</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.07"/>
                    <measurement group_id="O2" value="-0.14" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.40</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.07</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.07"/>
                    <measurement group_id="O2" value="-0.16" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0137</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.32</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.12</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.07"/>
                    <measurement group_id="O2" value="0.01" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0866</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.16</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.09</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.07"/>
                    <measurement group_id="O2" value="-0.13" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0656</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.23</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.12</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Ciliary Artery End Diastolic Blood Flow Velocity (cm/s) - No DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior ciliary artery end diastolic blood flow velocity (cm/s) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.08"/>
                    <measurement group_id="O2" value="0.01" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0626</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.19</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.09</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.008" spread="0.007"/>
                    <measurement group_id="O2" value="-0.005" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8100</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.003</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.013</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
        <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ophthalmic Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
          <description>change (post-treatment - pre-treatment) in ophthalmic artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.005" spread="0.006"/>
                    <measurement group_id="O2" value="-0.004" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.9556</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.001</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.010</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.019" spread="0.010"/>
                    <measurement group_id="O2" value="-0.004" spread="0.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3414</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.015</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.015</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
        <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Retinal Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
          <description>change (post-treatment - pre-treatment) in central retinal artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.017" spread="0.007"/>
                    <measurement group_id="O2" value="0.004" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0330</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.021</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.009</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.005" spread="0.007"/>
                    <measurement group_id="O2" value="0.005" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3326</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.010</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.010</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
        <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Nasal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
          <description>change (post-treatment - pre-treatment) in nasal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.022" spread="0.010"/>
                    <measurement group_id="O2" value="0.005" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0348</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.027</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.012</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.006" spread="0.009"/>
                    <measurement group_id="O2" value="0.010" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2089</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.016</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.012</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
        <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Temporal Posterior Artery Blood Flow - Vascular Resistance (Ratio) - No DM</title>
          <description>change (post-treatment - pre-treatment) in temporal posterior artery blood flow - vascular resistance (ratio) using color Doppler imaging (CDI) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.012" spread="0.009"/>
                    <measurement group_id="O2" value="-0.001" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3738</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.010</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.012</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ocular Perfusion Pressure - DM</title>
        <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ocular Perfusion Pressure - DM</title>
          <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.2"/>
                    <measurement group_id="O2" value="-1.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4470</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.7</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Ocular Perfusion Pressure - No DM</title>
        <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Ocular Perfusion Pressure - No DM</title>
          <description>change (post-treatment - pre-treatment) in Ocular perfusion pressure in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="1.4"/>
                    <measurement group_id="O2" value="3.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6382</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.1</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - DM</title>
        <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - DM</title>
          <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.031" spread="0.009"/>
                    <measurement group_id="O2" value="0.012" spread="0.010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0026</p_value>
            <method>paird t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.043</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.012</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</title>
        <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Superior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</title>
          <description>change (post-treatment - pre-treatment) in superior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.021" spread="0.014"/>
                    <measurement group_id="O2" value="0.010" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1045</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.030</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.018</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - DM</title>
        <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - DM</title>
          <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients with type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.005" spread="0.009"/>
                    <measurement group_id="O2" value="0.000" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6941</p_value>
            <method>paired t-test</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.005</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.013</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</title>
        <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
        <time_frame>baseline and 30 days</time_frame>
        <population>patients completing both study periods</population>
        <group_list>
          <group group_id="O1">
            <title>Dietary Supplement With Antioxidants</title>
            <description>Dietary supplement with antioxidants, Ginkgo biloba, Bilberry extract
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo identical in appearance to active
Softgels manufactured to mimic the appearance of active dietary supplement with antioxidants</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Inferior Retinal Capillary Blood Flow (% Zero Pixels) - No DM</title>
          <description>change (post-treatment - pre-treatment) in inferior retinal capillary blood flow (% zero pixels or % avascular tissue) using Heidelberg Retinal Flowmeter (HRF) in patients without type 2 diabetes</description>
          <population>patients completing both study periods</population>
          <units>% zero pixels</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.028" spread="0.009"/>
                    <measurement group_id="O2" value="0.018" spread="0.010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0138</p_value>
            <method>paired t-test, 2-sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.046</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.017</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>dietary supplement with antioxidants  placebo</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Four weeks for each intervention, with a 3-week wash out period between interventions</time_frame>
      <desc>Safety population included all participants who completed study. (45 patients with OAG were enrolled, 42 of which were followed through to completion of the study. Three patients discontinued study participation due to difficulty in adhering to study visit timeline.)</desc>
      <group_list>
        <group group_id="E1">
          <title>Supplement w/ Antioxidants</title>
          <description>dietary supplement with antioxidants
dietary supplement with antioxidants: Formulation contains vitamins, a mineral, dietary antioxidants, amino acids, polyphenols and polyunsaturated fatty acids</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>placebo supplement
Placebo: Placebo - Softgels manufactured to mimic the appearance of active, dietary supplement with antioxidants</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brent Siesky, PhD, Assistant Director</name_or_title>
      <organization>Ocular Vascular Research Center, Indiana University School of Medicine</organization>
      <phone>317-278-0177</phone>
      <email>bsiesky@indiana.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

